Book Navigation
 

Meet the plenary speakers

Lisa Askie.jpgDr Lisa Askie

Dr Askie is the Director of Systematic Reviews and Health Technology Assessment at the NHMRC Clinical Trials Centre, University of Sydney. She is also manager of the Australian New Zealand Clinical Trials Registry. Lisa’s clinical background is in perinatal medicine and she has worked in healthcare systems in Asia, Australia, the UK and USA. She has masters and doctoral qualifications in epidemiology from the Faculty of Medicine, and is a Senior Research Fellow and an NHMRC Career Development Award Fellow at the University of Sydney.

Dr Askie has a long standing interest in the conduct and methodology of clinical trials, systematic reviews and clinical practice guidelines. She has been involved with the Cochrane Collaboration since 1996 as a systematic review author and trainer and is a co-convenor of the Cochrane Prospective Meta-analysis Methods Group. Dr Askie coordinates several individual patient data and prospective meta-analysis international collaborations mainly in the areas of paediatric and perinatal medicine. She has published over 30 scientific papers and is a member of various health and academic advisory boards.

Karen Daniels.jpgKaren Daniels

Karen Daniels is a Senior Scientist at the Health Systems Research Unit of the Medical Research Council, South Africa.  She is a qualitative researcher with a strong interest in policy making and knowledge translation.  Between 2004 and 2005 Ms Daniels collaborated on a three country Southern African study which explored research utilisation in guidelines and policy making for maternal health and malaria. In June 2010 the study team won first prize in the category of Medicine for BioMed Central’s 4th Annual Research Award. Ms Daniels is currently engaged in a PhD thesis focusing on community health workers particularly in relation to gender and policy making. The Health Systems Research Unit continues to investigate the problems which deter the delivery of health care in South Africa and aims to improve this by means of effective and simple health care interventions.

Leonila Dans.jpgLeonila Dans

Leonila F. Dans MD MS is professor at the University of the Philippines, Department of Pediatrics and Department of Clinical Epidemiology.  She received her Master degree in 1991 at Mc Master University in Ontario, Canada. She is specialised within the field of Pediatrics, Pediatric Rheumatology and Clinical Epidemiology. She has done research work within the field of Pediatrics and Rheumatology. She has been a Cochrane Reviewer since 2000. She has been involved in introducing Evidence-based Medicine and Evidence-based Clinical Practice Guidelines in the Philippines and in the Asia-Pacific region. She is a Member Emeritus of the American College of Rheumatology, member of the International Clinical Epidemiology Network, and Advisory Editorial Board member of Journal of Clinical Epidemiology.  She is presently a member of the WHO Expert Advisory Panel on Clinical Practice Guidelines and Research Methods and Ethics and WHO Guidelines Review Committee. She has authored several journal articles and book chapters, with special interest on issues of applicability and equity. Her most recent publication is a user-friendly simplified book entitled “Painless Evidence-Based Medicine” targeted for EBM practitioners.

Dave Davis 2009Dr Dave Davis

Currently the AAMC’s lead for continuing healthcare education and improvement, Dave was a family physician in Ontario, Canada for nearly forty years. For much of that time, he was active in `CME´ as: chairman of an all-staff inter-professional CE program at a community hospital; director of Continuing Medical Education and subsequently chair of continuing education at McMaster University’s Faculty of Health Sciences; associate dean, continuing education, and founding director of the Knowledge Translation Program in the Faculty of Medicine, University of Toronto; and chairman of Ontario’s Guidelines Advisory Committee. This last role allowed Dave the opportunity to explore and test models of clinical practice guideline development, adaptation and implementation on a province-wide basis. His (and colleagues’) 1995 JAMA systematic review of the effect of CME interventions is widely cited as a seminal study in this field.

Finally, Dave has been chair or president of national or provincial Canadian organisations, two North American organisations (the Alliance for CME and the Society for Academic CME) and G-I-N. His current role in the AAMC permits him the opportunity to work with individuals, associations, groups and academic medical centers to create scholarly, integrated models of effective, performance-based continuing education.

Tsuguya Fukui.jpgTsuguya Fukui

Dr. Tsuguya Fukui is the president of St. Luke’s International Hospital, one of the most prestigious hospitals in Japan. St. Luke’s International Hospital has been playing central role in improving medical care in Japan through the development and introduction of innovative systems and postgraduate training of doctors and allied health professionals. Dr. Fukui has been one of the leaders in advancing general internal medicine, clinical epidemiology, and medical education in Japan and was previously the professor of medicine and clinical epidemiology as well as the founding Dean of School of Public Health at Kyoto University Graduate School of Medicine. Dr. Fukui is also president of The Japan Medical Library Association, Japanese Society of Clinical Pathway and a board member of various organizations including National Hospital Organization, Japan Hospital Association and Yokohama Municipal Medical College. He has also been serving as a member of various committees of the Ministry of Health, Labor and Welfare and Ministry of Education, Culture, Sports, Science and Technology. He is also an adjunct professor of School of Biomedical Informatics, University of Texas, USA, and Jichi Medical School, Tochigi, Japan.

Hernando Gaitan.png.jpgHernando G. Gaitan

Dr. Gaitán (MD, MSc) is a specialist in obstetrics and gynaecology; he is also a clinical epidemiologist. He is currently a professor in the Universidad Nacional de Colombia’s Obstetrics and Gynaecology Department and the Clinical Research Institute. The Universidad Nacional is the main public university in Colombia.

He has a special interest in patient safety research, health technology assessment and guideline development. His research into patient safety research has included:  tools and methodologies   for detecting and qualification of adverse events and risk management system assessment. Regarding HTA, he is interested in evaluating the effectiveness and accuracy of diagnostic interventions and intervention effectiveness (RCT and SR). His work in clinical practice guidelines has included adapting and de novo development (preeclampsia and syndromic management of sexually transmitted infections and genital tract infection guidelines). He has published more than ten papers in international journal and two Cochrane SR.

Paul GlasziouPaul Glasziou

Paul Glasziou is currently the Director of the Centre for Evidence-Based Medicine, and Professor of Evidence-Based Medicine in the department of Primary Care at the University of Oxford, and also continues work as a part-time General Practitioner. He is the author of over 150 peer-reviewed publications in medical decision making, clinical trials, systematic reviews and evidence-based medicine. He is editor of the BMJs journal of Evidence-Based Medicine. He is a member of the management committee of the 3 largest clinical trials ever conducted in Australia: the LIPID, FIELD, and ADVANCE studies. He has published 6 books on evidence-based health care and decision making: Systematic Reviews in Health Care; Decision Making in Health Care and Medicine: integrating evidence and values; An Evidence-Based Medicine Workbook; Clinical Thinking: Evidence, Communication and Decision-making; Evidence-Based Medicine: How to Practice and Teach EBM; and Evidence-Based Medical Monitoring: Principles and Practice. In 2008 he was awarded an NHMRC Australia Fellowship, and will move back to Australia.

Tamaro Kredo.jpgTamaro Kredo

Tamara Kredo is a specialist in clinical pharmacology and currently holds the position of senior specialist scientist at the South African Cochrane Centre, South African Medical Research Council. She obtained her MBChB degree (1998) and a Masters in Clinical Pharmacology (2008) at the University of Cape Town. She has a special interest in evidence-based healthcare practice and training, rational therapeutics and clinical practice guidelines. Her research interests have included the safety and interactions of anti-malarials and antiretrovirals in patients with HIV and she has also been responsible for pushing new malaria related policy by establishing a special access programme for the use of the WHO essential medicine Artesunate for the treatment of severe malaria in South Africa. Her current research focuses on the quality and content of clinical practice guidelines within the Southern African Development Community (SADC). This work forms part of a broader project to harmonise essential medicines lists and clinical practice guidelines within SADC to facilitate equitable regional procurement of medicines and devices.

Ilkka Kunnamo.jpgIlkka Kunnamo

Ilkka Kunnamo, MD, PhD, developed the original idea of Evidence-Based Medicine Guidelines, a comprehensive electronic guideline database published by Duodecim Medical Publications Ltd., and has been its editor-in-chief since 1988. Since 1986, he has served as general practitioner at the Health Centre of Karstula in Central Finland. In 2009, he was appointed adjunct professor of general practice in the University of Helsinki. He has been involved in a number of projects on primary care computing, medical informatics, and the organization of primary care. In 2002, he was the leader of the team that produced the plan for the development of a nationwide, standardized electronic health record for Finland. Presently he develops a decision support service (Evidence-Based Medicine electronic Decision Support, EBMeDS, www.ebmeds.org) utilizing the key data sets in the health record. He has published research papers in rheumatology, gastroenterology, sinusitis, diabetes care and informatics. He is a member of the Editorial Board of BioMed Central (London) and a member of the international GRADE group.

Ken KuoKen Kuo

Ken N Kuo, MD is the Director and Professor at the Division of Health Policy Research and Development, Institute of Population Health Sciences, National Health Research Institutes, and National Taiwan University Hospital. He is a well recognized internationally in pediatric orthopedics and active in international and North American societies. He serves as editorial reviewer in many orthopedic journals internationally. In the field of health policy research, he had conducted many projects in Taiwan, including physician health workforce study, Tobacco Control Forum, IRB Accreditation, EBM and CPG as well as education and promotion. He serves in advisory capacity to Department of Health in Taiwan on graduate medical education, health promotion. He recently conducted white paper on Healthy People 2020 in Taiwan.

Gillian Leng.jpgDr Gillian Leng

Dr Gillian Leng is the Director of Evidence and Practice, a role which encompasses the NICE implementation function and responsibility for NHS Evidence. NHS Evidence is a service designed to improve use of, and access to, evidence-based information about health and social care. It provides access to a range of evidence-based information - primary research, summarised evidence, reports and practical evidence-based tools to support implementation.  A formal programme accredits external guidance producers.  The NICE implementation programme provides support to key audiences and organisations, within and beyond the NHS, to maximise uptake and use of evidence and guidance.  The programme aims to motivate and encourage change in practice by working through other organisations and systems within the NHS and partner organisations, to provide practical support, and monitor uptake of the recommendations to inform future work.  Gillian is also the Deputy Chief Executive of NICE, a role encompassing strategic planning plus other general corporate responsibilities.

Previously Gillian worked as the Guidelines Programme Director at NICE, and before that at Bedfordshire Health Authority as a consultant in public health medicine with responsibility for clinical governance and implementing national service frameworks. She is also an editor of the Cochrane Review Group on peripheral vascular diseases and an honorary senior lecturer at the London School of Hygiene and Tropical Medicine. Research interests include the methodology for evaluating and reviewing evidence, clinical trials and implementation science.

Nicola Magrini.jpgNicola Magrini

Graduated in Medicine at the University of Bologna and specialised in clinical pharmacology at the University of Milan. He trained in RCT methodology and metanalysis at Mario Negri Institute in Milan in 1989-1991. He is a founder member of the Italian Cochrane Centre (1996) and was involved since 1999 in creating and establishing a NHS Centre (NHS CeVEAS, Centre for the Evaluation of the Effectiveness od Health Care, Modena, Italy) devoted to research synthesis and knowledge transfer in particular for the evaluation of new drugs and also involved in the methodological support to guideline production and implementation at national and regional level. He is a member of the GRADE working Group and contributed to the development of the WHO Handbook on Guideline Development (2008).  He has been Cahirman of the Ethics Committee of Reggio Emilia Hospital since 1997 and member of BMJ editorial board (2002-2006). Dr Magrini is presently Director of NHS CeVEAS which has become WHO Collaborating Centre in evidence-based research synthesis and guideline development since 2008 and  he is member of the WHO Expert Advisory Panel on Drug Evaluation (2011-2014). His main research interest are in defining new formats to synthesise available information on benefits and risks of drugs, better ways to explicitly present guideline and Panel work methodology and pragmatic RCTs design. He is also actively involved in medicines selection policy and in improving drug registration process.

Hans Messersmith.jpgHans Messersmith

Hans Messersmith joined McMaster University in Hamilton, Ontario, Canada, in 2004 as a research coordinator in the Program in Evidence-Based Care (PEBC).  His primary work with the PEBC is in developing and ensuring the use of methods for the efficient and timely development of high quality systematic reviews, meta-analyses, and clinical practice guidelines.  He is currently the Assistant Director, Quality and Methods, for the PEBC.   Prior to joining McMaster University, he worked for the Indiana State Department of Health in the United States in many capacities over fourteen years, most recently as the Director of Surveillance and Investigation for infectious disease.  Hans has a Masters Degree in Public Health from the Indiana University School of Medicine.

Rick ShiffmanDr Richard Shiffman

Richard Shiffman is Professor of Paediatrics and Associate Director of the Center for Medical Informatics at Yale School of Medicine. He is a Fellow of the American College of Medical Informatics and the American Academy of Paediatrics (AAP). Dr. Shiffman has served on several guideline development panels for national professional societies and on the Institute of Medicine Committee to Develop Standards for Trustworthy Guidelines. From 2008-2010 he served on the Board of Directors of the Guidelines International Network and the Advisory panel for the National Guidelines Clearinghouse/National Quality Measures Clearinghouse. Last year he served as Scientific Program Chair for G-I-N’s Annual Meeting in Chicago. Dr. Shiffman leads the GLIDES Project—an AHRQ-sponsored initiative to define best practices for clinical decision support based on guidelines. Dr. Shiffman’s research investigates the transformation of knowledge from clinical practice guidelines into computer-based decision support systems. He convened the Conference on Guideline Standardization in 2002 and his team at Yale developed GEM (the Guideline Elements Model)— an international standard for representation of guideline documents, the COGS (Conference on Guideline Standardization) checklist for appraising guideline quality, GLIA (the GuideLine Implementability Appraisal)—an instrument to identify obstacles to guideline implementation and BRIDGE-Wiz—a software assistant to facilitate the development of clear, transparent, and implementable guideline statements.

Philip van der Wees May 2010Philip van der Wees

Philip van der Wees is physical therapist and human movement scientist from Amsterdam, the Netherlands. He finished his doctoral thesis in 2009, in which he evaluated the development and implementation of evidence-based clinical guidelines in physical therapy. He currently works as Program Manager Quality & Implementation in a joint program of the Royal Dutch Society for Physical Therapy, Radboud University Nijmegen Medical Centre (IQ healthcare), and Maastricht University (Caphri Research Institute). He is the current Chair of the G-I-N Board of trustees and chairs the allied health community. For more information on Philip and his background please click here.

 
December 2016
  «
»
December
MoTuWeThFrSaSu
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Page last updated: Sep 13, 2011
Copyright © 2002-2016 Guidelines International Network.
All rights reserved

The Guidelines International Network is formally constituted as a Scottish Guarantee Company under Company Number SC243691 and recognised as a Scottish Charity under Scottish Charity Number SC034047 with its Registered Office at J. & H. Mitchell W.S., 51 Atholl Road, Pitlochry, Perthshire PH16 5BU, Scotland.

Back to top